EXAGEN INC. (XGN)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 17,202 | 15,498 | 12,507 | 15,064 |
| Gross margin | 10,395 | 9,123 | - | - |
| Cost of revenue | 6,807 | 6,375 | 5,526 | 6,008 |
| Selling, general and administrative expenses | 11,542 | 11,204 | 10,163 | 10,464 |
| Research and development expenses | 1,483 | 1,284 | 1,481 | 1,179 |
| Total operating expenses | 13,025 | 12,488 | 17,170 | 17,651 |
| Loss from operations | -2,630 | -3,365 | -4,663 | -2,587 |
| Interest income | 85 | 158 | 197 | 181 |
| Interest expense | 1,124 | 545 | 562 | 560 |
| Loss on extinguishment of debt | -295 | - | - | - |
| Change in fair value of warrant liability | 438 | - | - | - |
| Loss before income taxes | -4,402 | - | - | - |
| Income tax expense | 37 | - | - | - |
| Net loss | -4,439 | -3,752 | -5,028 | -2,966 |
| Net loss per share, basic (in dollars per share) | -0.21 | -0.2 | -0.28 | -0.16 |
| Net loss per share, diluted (in dollars per share) | -0.21 | -0.2 | -0.28 | -0.16 |
| Weighted-average number of shares used to compute net loss per share, basic (in shares) | 21,085,749 | 18,557,390 | 18,254,937 | 18,178,185 |
| Weighted-average number of shares used to compute net loss per share, diluted (in shares) | 21,085,749 | 18,557,390 | 18,254,937 | 18,178,185 |